Fabiola Puentes

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Antibodies to neurofilament light as potential biomarkers in multiple sclerosis.

Antibodies to neurofilament light as potential biomarkers in multiple sclerosis.

Journal: BMJ neurology open

Published: June 22, 2021

Imaging immunological processes from blood to brain in amyotrophic lateral sclerosis.

Imaging immunological processes from blood to brain in amyotrophic lateral sclerosis.

Journal: Clinical and experimental immunology

Published: June 08, 2021

Humoral response to neurofilaments and dipeptide repeats in ALS progression.

Humoral response to neurofilaments and dipeptide repeats in ALS progression.

Journal: Annals of clinical and translational neurology

Published: April 27, 2021

Analysis of circulating protein aggregates as a route of investigation into neurodegenerative disorders.

Analysis of circulating protein aggregates as a route of investigation into neurodegenerative disorders.

Journal: Brain communications

Published: October 10, 2020

Science is 1% inspiration and 99% biomarkers.

Science is 1% inspiration and 99% biomarkers.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 25, 2017

Neurofilament light as an immune target for pathogenic antibodies.

Neurofilament light as an immune target for pathogenic antibodies.

Journal: Immunology

Published: February 06, 2017

Immune Modulation and Prevention of Autoimmune Disease by Repeated Sequences from Parasites Linked to Self Antigens.

Immune Modulation and Prevention of Autoimmune Disease by Repeated Sequences from Parasites Linked to Self Antigens.

Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

Published: May 01, 2016

Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS Barriers.

Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS Barriers.

Journal: Brain pathology (Zurich, Switzerland)

Published: December 17, 2015

Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis.

Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis.

Journal: The Journal of biological chemistry

Published: October 29, 2015

Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective.

Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective.

Journal: International immunology

Published: October 27, 2014

Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis.

Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: February 12, 2014

Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis.

Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: October 01, 2013

Showing 1-12 of 16

Last Updated: 09/26/2026